Please use this identifier to cite or link to this item:
10.12955/cbup.v4.821
Title: | CARDIOEMBOLIC STROKE IN LATVIA : PREVENTION AND LONG-TERM OUTCOME |
Authors: | Pucite, Elina Jurjans, Kristaps Miglane, Evija Lurina, Baiba Kalējs, Oskars Millers, Andrejs Priede, Zanda Department of Neurology and Neurosurgery Department of Internal Diseases |
Keywords: | Atrial fibrillation;cardio embolic stroke;stroke mortality;primary stroke prevention;secondary stroke prevention;3.2 Clinical medicine;3.1. Articles or chapters in proceedings/scientific books indexed in Web of Science and/or Scopus database |
Issue Date: | 2016 |
Publisher: | Central Bohemia University |
Citation: | Pucite , E , Jurjans , K , Miglane , E , Lurina , B , Kalējs , O , Millers , A & Priede , Z 2016 , CARDIOEMBOLIC STROKE IN LATVIA : PREVENTION AND LONG-TERM OUTCOME . in CBU International Conference on Integration and Innovation in Science and Education : proceedings . vol. 4 , CBU INTERNATIONAL CONFERENCE PROCEEDINGS 2016: INNOVATIONS IN SCIENCE AND EDUCATION , Central Bohemia University , Prague , pp. 615-621 , CBU International Conference on Innovations in Science and Education , Prague , Czech Republic , 23/06/16 . https://doi.org/10.12955/cbup.v4.821 conference |
Series/Report no.: | CBU INTERNATIONAL CONFERENCE PROCEEDINGS 2016: INNOVATIONS IN SCIENCE AND EDUCATION |
Abstract: | NTRODUCTION:Untreated non-valvular atrial fibrillation is one of major causes of stroke. The goalof the study was to evaluate the use of antithrombotic medication stroke prevention and assess long-term stroke outcome.METHODS:This study involved 531 cardio embolicstroke patients of thePaul’sStradins Clinical University Hospital, Riga, Latvia,in 2014. After dischargethe patients or their relatives were interviewed by phone after 30, 90, 180, and 365 days. Standardized questions were asked about the patients’abilities and use of prescribed secondary prevention medication. Theresults were compared between patient groups, assigned according to prescribed medications. RESULTS:Of all the patients included in the study,8.9% were using oral anticoagulants before stroke onset. One year after discharge,1.44% of patients were not using any preventivemedication, 23.56%were using antiplatelet agents, 43.27% warfarin,and 31.73% target-specificoralanticoagulants. The one-year mortality ratewas 40.7%. The mortality rate was significantly higher in the patient group using no secondary preventivemedication or antiplatelet agents compared to the patient group that used oral anticoagulants. CONCLUSION:Cardio embolicstroke primary and secondary prevention in Latvia islacking. The study outcomes suggest that action is neededto increase the use of oral anticoagulants in primary stroke prevention in patients with atrial fibrillation. Poor function outcomes, dementia,and patients’incompliance limits the use of oral anticoagulants in secondary prevention |
DOI: | 10.12955/cbup.v4.821 |
ISBN: | 978-80-88042-04-4 |
ISSN: | 1805-997X |
Appears in Collections: | Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure |
Files in This Item:
File | Size | Format | |
---|---|---|---|
CARDIOEMBOLIC_STROKEIN_LATVIA.pdf | 440.99 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.